Table 5.

Number of participants reporting treatment-emergent psychiatric adverse events

	Placebo (n = 4)	MDMA (n = 8)
Psychiatric TEAEs, no. (%)a
Anxiety	0	1 (12.5)b
Depressed mood	0	2 (25.0)
Depression	1 (25.0)	1 (12.5)c
Panic attack	0	1 (12.5)b
Panic reaction	0	1 (12.5)
Suicidal ideation	1 (25.0)	2 (25.0)b
None	3 (75.0)	4 (50.0)

Abbreviations: TEAEs, treatment emergent adverse events

^aFrequency of subjects who self-reported psychiatric adverse events after first drug administration until the primary endpoint

^bOne moderate

^cTwo moderate